|
Follow-on Drug Development
|
|
Wednesday, December 15, 2004
|
 |
| Panelists discuss the pharmaceutical industry's development of "follow-on" drugs and whether or not consumers benefit from such a practice. |
|
|
Improving Health Care
|
|
Monday, November 8, 2004
|
|
| A discussion of the proper role of competition in health care markets in light of a recent Federal Trade Commission and Department of Justice joint report on improving health care. |
|
|
What Happened to the European Pharmaceutical Industry?
|
|
Thursday, October 7, 2004
|
|
| Professor Fabio Pammolli of the University of Florence describes the nature and causes of the momentous shift in the pharmaceutical market from Europe to America. |
|
|
Show Us the Data
|
|
Monday, September 20, 2004
|
|
| Panelists discuss the benefits and unintended negative consequences of various public database scenarios and appraise alternative approaches to the subject of disclosure. |
|
|
Assuring Vaccine Supply
|
|
Thursday, April 15, 2004
|
|
| Four experts offer their perspectives on how to improve public policies toward vaccine supply, with emphasis on the roles of the industry, the medical community, the CDC, and the FDA. |
|
|
The Price of Pharmaceuticals
|
|
Friday, December 12, 2003
|
|
| Patricia Danzon presents her new research comparing U.S. drug policies to those in Canada and other countries, and the effect of price controls on the availability of new drugs. |
|
|
Medicare after Reform
|
|
Thursday, December 4, 2003
|
|
| Health experts and representatives of employers and consumers assess the Medicare compromise bill. |
|
|
Tackling Malaria
|
|
Tuesday, December 2, 2003
|
|
| Experts discuss the controversial role of DDT in malaria prevention and the problems of developing and using drug treatments for malaria. |
|
|
A New Approach to Vaccine Development
|
|
Monday, December 1, 2003
|
|
| A panel consisting of Institute of Medicine members and other experts presents and discusses the IOM's findings in its report on vaccine development. |
|
|
Unrestricted Prescription-Drug Importation from Canada and Elsewhere
|
|
Thursday, October 2, 2003
|
|
| Legislators, regulators, and scholars discuss the implications of legalized pharmaceutical reimportation. |
|
|
| Total Records: 50 |
|
